Thanks for the share.
Indeed there's enormous interest in improved therapies & fibrotic diseases in general. Indeed a panel at this year's JP Morgan Healthcare Conference named fibrosis as a top 3 areas of importance/interest to big pharma.
Accordingly, there is a very active partnering landscape with many Big Pharma actively looking for new & improved anti fibrotic therapies as highlighted by the billion dollar and early deals in the space. Exciting days ahead.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4.358K | 2.178M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 26349399 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 6805828 | 16 |
View Market Depth
| Last trade - 13.08pm 24/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |